Skip to main content
logo
Renalytix Plc (AIM:RENX)
London flag London · Delayed Price · Currency is GBP · Price in GBX
6.75
0.00 (0.00%)
At close: Dec 5, 2025

Renalytix Revenue

In the fiscal year ending June 30, 2025, Renalytix had annual revenue of $3.00M USD with 30.43% growth. Renalytix had revenue of $1.25M in the quarter ending December 31, 2024, with 76.45% growth.

Revenue
$3.00M
Revenue Growth
+35.07%
P/S Ratio
13.47
Revenue / Employee
n/a
Employees
n/a
Market Cap
29.50M GBP

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year EndRevenueChangeGrowth
Jun 30, 20253.00M700.00K30.43%
Jun 30, 20242.30M-1.10M-32.41%
Jun 30, 20233.40M433.00K14.58%
Jun 30, 20222.97M1.48M99.20%
Jun 30, 20211.49M--
Jun 30, 2020 Pro Pro Pro
Jun 30, 2019 Pro Pro Pro
Jun 30, 2018 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
AstraZeneca43.24B
GSK plc32.17B
Haleon11.02B
Smith & Nephew4.33B
Hikma Pharmaceuticals2.35B
Convatec Group1.72B
Spire Healthcare Group1.55B
Genus672.80M
Revenue Rankings

Renalytix News

More News